Adjunctive use of celecoxib with anti-tuberculosis drugs: evaluation in a whole-blood bactericidal activity model
10.1038/s41598-018-31590-4
Saved in:
Main Authors: | Naftalin C.M., Verma R., Gurumurthy M., Hee K.H., Lu Q., Yeo B.C.M., Tan K.H., Lin W., Yu B., Seng K.Y., Lee L.S.-U., Paton N.I. |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
Nature Publishing Group
2019
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/152066 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Activity of faropenem with and without rifampicin against Mycobacterium tuberculosis: evaluation in a whole-blood bactericidal activity trial
by: Gurumurthy, Meera, et al.
Published: (2021) -
Coadministration of Allopurinol To Increase Antimycobacterial Efficacy of Pyrazinamide as Evaluated in a Whole-Blood Bactericidal Activity Model
by: Naftalin, Claire M, et al.
Published: (2021) -
Impact of selective immune-cell depletion on growth of Mycobacterium tuberculosis (Mtb) in a whole-blood bactericidal activity (WBA) assay
by: Cross, Gail B, et al.
Published: (2021) -
A novel F420-dependent anti-oxidant mechanism protects Mycobacterium tuberculosis against oxidative stress and bactericidal agents
by: Gurumurthy, M., et al.
Published: (2014) -
Sufficient evidence to consider hydroxychloroquine as an adjunct therapy in antiphospholipid antibody (Hughes') syndrome [2]
by: Yoon, K.H.
Published: (2014)